SPYR Building Its Mobile Games Division as Revenues in the Digital Games Industry Are Projected to Balloon to $100 Billion by 2018
14 oct. 2015 09h15 HE
|
SPYR, Inc.
NEW YORK, NY--(Marketwired - October 14, 2015) - Executives at SPYR, Inc. (OTCQB: SPYR) are surely aware of the growing revenue numbers that are being projected for the digital games industry. The...
Armed With FDA Orphan Drug Status in the U.S., PharmaCyte Biotech Now Securing Europe for Pancreatic Cancer Treatment
09 oct. 2015 09h25 HE
|
PharmaCyte Biotech, Inc.
BONITA, CA--(Marketwired - October 09, 2015) - The combination of PharmaCyte Biotech’s (OTCQB: PMCB) signature live-cell encapsulation technology, Cell-in-a-Box® with low doses of ifosfamide has...
PharmaCyte Biotech Moves Closer to Revealing Plan to Address Unmet Medical Need in Phase 2b Clinical Trial
30 sept. 2015 09h30 HE
|
PharmaCyte Biotech, Inc.
BONITA, CA--(Marketwired - September 30, 2015) - Cancer is the world's second most common cause of death, not too far behind heart disease. And, although no form of cancer is "good," pancreatic cancer...
SPYR Lands Brand Building Heavyweight to Gain Competitive Advantage in Multi-Billion Dollar Mobile Games and Apps Industry
11 sept. 2015 09h00 HE
|
SPYR, Inc.
NEW YORK, NY--(Marketwired - September 11, 2015) - SPYR, Inc. (OTCQB: SPYR) appears ready to build its mobile game and app development business into a real player in the industry, and they’ve turned...
Plandai Biotechnology, Inc. Announces USN Developing New Products Using Phytofare(R)
26 août 2015 09h00 HE
|
Plandai Biotechnology, Inc.
GOODYEAR, AZ--(Marketwired - August 26, 2015) - Plandaí Biotechnology, Inc. (OTCQB: PLPL) (“Plandaí” or “the Company”), producer of the highly bioavailable Phytofare® catechin complex, today announced...
SPYR Positioned to Capture Share of Increased Spending on Mobile Advertising
19 août 2015 09h00 HE
|
SPYR, Inc.
NEW YORK, NY--(Marketwired - August 19, 2015) - SPYR, Inc. (OTCQB: SPYR) spent the first half of 2015 expanding into two industries that are experiencing dramatic growth: digital publishing and...
PharmaCyte Biotech Has Only Scratched the Surface With Its Cell-in-a-Box(R) Technology
17 août 2015 09h00 HE
|
PharmaCyte Biotech, Inc.
BONITA, CA--(Marketwired - August 17, 2015) - PharmaCyte Biotech Inc. (OTCQB: PMCB) has made a name for itself with the company’s potentially game-changing pancreatic cancer treatment, and also as the...
Plandai Biotechnology, Inc. Announces Expansion of Agreement With USN to Now Include the European Union
10 août 2015 09h00 HE
|
Plandai Biotechnology, Inc.
GOODYEAR, AZ--(Marketwired - August 10, 2015) - Plandaí Biotechnology, Inc. (OTCQB: PLPL) (“Plandaí" or “the Company”), producer of the highly bioavailable Phytofare® catechin complex, today announced...
PharmaCyte Biotech's Improved Technology Attracting World Class Oncologists
30 juil. 2015 09h00 HE
|
PharmaCyte Biotech, Inc.
NEW YORK, NY--(Marketwired - July 30, 2015) - PharmaCyte Biotech (OTCQB: PMCB) is a small international biotechnology firm, but you wouldn't know it by the company it keeps. How does PharmaCyte keep...
Celgene May Also Want to Take Notice of PharmaCyte Biotech
24 juil. 2015 09h00 HE
|
PharmaCyte Biotech, Inc.
BONITA, CA--(Marketwired - July 24, 2015) - A recent deal between Celgene and Juno Therapeutics is just a microcosm of the mindset that may ultimately drive a similar deal between it -- or a...